logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Hong Kong Stock Exchange listed CXO concept stocks rose sharply at the beginning of trading, with Panada Holdings gaining over 23%.

date
23/07/2025
Hong Kong stocks' CXO concept stocks rose in the early trading session, with Fangda Holdings up more than 23%, Kanglong Chemicals, Kailaiying up more than 4%, and Pharmaron, Pharmaron Conde, and Tasly Pharmaceuticals all rising.
Latest
1 m ago
Changman Holdings (08523.HK): The listing status will be cancelled starting from July 28th.
2 m ago
National Medical Products Administration: Currently, China's research and development pipeline for innovative drugs accounts for about 1/4 of the global total.
2 m ago
Territory Holdings (06999.HK): Luo Ying resigns as independent non-executive director.
3 m ago
Essence Pharma: Subsidiary Nantong Company Obtains Notification of Approval for Lopinavir "Chemical Raw Material Drug Listing Application"
3 m ago
Dohwa Corporation: After the controlling shareholder released the pledge of 22.32 million shares, they pledged an additional 18.11 million shares.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.